Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
CCL2 induction by 1,25(OH)2D3 in dendritic cells from healthy donors and multiple sclerosis patients.
Iron chelation and multiple sclerosis.
Optic neuritis and the evaluation of visual impairment in multiple sclerosis.
Neuro-ophthalmology update.
Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple Sclerosis.
Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation.
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study.
The Olig family affects central nervous system development and disease.
Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes.
11C-Acetate PET Imaging in Patients with Multiple Sclerosis.
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.
Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
Interferon Beta and vitamin d synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.
Optic Neuritis and the Visual Pathway: Evaluation of Neuromyelitis Optica Spectrum by Resting-State fMRI and Diffusion Tensor MRI.
The Blood-Brain Barrier in Multiple Sclerosis: MicroRNAs as Key Regulators.
Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
Synaptic vesicle release regulates myelin sheath number of individual oligodendrocytes in vivo.
Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis.
Immune reconstitution inflammatory syndrome and natalizumab-Is it possible before removing the drug?
Downregulation of Sphingosine 1-Phosphate Receptor 1 Promotes the Switch from Tangential to Radial Migration in the OB.
Muscle Expression of SOD1(G93A) Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice.
Pages
« first
‹ previous
…
424
425
426
427
428
429
430
431
432
…
next ›
last »